A cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.
UK experts say the low-dose steroid treatment is a major breakthrough in the fight against the deadly virus.
It cut the risk of death by a third for patients on ventilators and for those on oxygen, it cut deaths by a fifth.
The drug is part of the world’s biggest trial testing existing treatments to see if they also work for coronavirus.
Researchers estimate that if the drug had been available in the UK from the start of the coronavirus pandemic up to 5,000 lives could have been saved. Because it is cheap, it could also be of huge benefit in poor countries struggling with high numbers of COVID-19 patients.
About 19 out of 20 patients who get coronavirus get better without coming to hospital.
For those who are admitted to hospital, most also get better, but some may need oxygen or mechanical ventilation.
These are the high risk patients that dexamethasone appears to help.
The drug is already used to reduce inflammation in a range of other conditions, and it appears that it helps stop some of the damage that can happen when the body’s immune system goes into overdrive as it tries to fight off coronavirus.
The body’s over-reaction is called a cytokine storm and it can be deadly.
In the trial, led by a team from Oxford University, around 2,000 hospital patients were given dexamethasone and were compared with more than 4,000 who did not get the drug.
For patients on ventilators it cut death risk from 40% to 28% and for patients needing oxygen it cut death risk from 25% to 20%.
Chief investigator Prof Peter Horby said, “This is the only drug so far that has been shown to reduce mortality and it reduces it significantly. It’s a major breakthrough.”
Lead researcher Prof Martin Landray says the findings suggest that for every eight patients needing ventilators that you treat, you could save one life.
In patients on oxygen, you save one life for every 20-25 or so treated with the drug.
“There is a clear, clear benefit. The treatment is up to 10 days of dexamethasone and it costs about £5 per patient. So essentially it costs £35 to save a life. This is a drug that is globally available.”
Prof Landray said, when appropriate, hospital patients should now be given it without delay, but people should not go out and buy it to take at home.
Dexamethasone does not appear to help people with milder symptoms of coronavirus – people who don’t need help with their breathing.
The Recovery Trial has been running since March and included the malaria drug hydroxychloroquine that has now been ditched amid concerns that it increases fatalities and heart problems.
Another drug called remdesivir, an antiviral treatment that appears to shorten recovery time for people with coronavirus, is already being made available on the NHS.
The first drug proven to cut deaths from covid-19 is not some new, expensive medicine but an old, cheap-as-chips steroid.
That is something to celebrate because it means patients across the world could benefit immediately.
That’s why the topline results of this trial have been rushed out because the implications are so huge globally.
About Dexamethasone
Dexamethasone has been used since the early 1960s to treat a wide range of conditions, such as rheumatoid arthritis and asthma.
Half of all COVID patients who require a ventilator do not survive, so cutting that risk by a third would have a huge impact.
The drug is given intravenously in intensive care, and in tablet form for less seriously ill patients. The only other drug proven to benefit Covid patients is remdesivir, an antiviral treatment that has been used for Ebola.
That has been shown to reduce the duration of coronavirus symptoms from 15 days to 11, but the evidence was not strong enough to show whether it reduced mortality. Unlike dexamethasone, remdesivir is a new drug with limited supplies and a price has yet to be announced.
